VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
EVOEvotec SE
$2.74$973M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksEVOBalance Sheet

Evotec SE (EVO) Balance Sheet

23Y historyFree accessUpdated daily

The company's financial position is increasingly vulnerable, as total equity has eroded to $700.3 million by 2026Q1 while maintaining a debt-to-equity ratio of 0.55.

EVO Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03
Total Current Assets712.02M762.62M681.96M903.16M1.07B1.1B806.13M527.05M249.77M180.25M169.24M166.94M125.3M122.53M88.1M83.33M86.69M68.96M93.08M111.84M113.82M81.97M65.5M34.74M
Cash & Short-Term Investments445.23M476.19M396.8M604.11M707.31M858.5M589.67M359.22M149.88M101.58M127.86M134.96M89.92M98.14M65.64M63.78M68.54M58.36M84.1M96.13M78.72M53.52M64.15M32.9M
Cash Only388.32M418.34M306.39M510.91M400.7M699.33M517.05M310.97M109.06M67.02M83.94M44.5M48.71M45.64M39.06M17.78M21.09M32.93M55.06M37.99M78.72M53.52M4.12M1.39M
Short-Term Investments56.91M57.85M90.41M93.2M306.61M159.17M72.62M48.25M40.82M34.56M43.92M90.46M41.21M52.49M26.57M46.01M47.45M25.43M29.03M58.14M0060.03M31.51M
Accounts Receivable167.23M213.42M218.38M221.9M275.77M176.75M167.48M139.34M60.94M69.98M29.83M22.19M26.15M18.21M15.53M10.59M12.44M4.86M3.9M9.17M7.77M14.13M16.34M0
Days Sales Outstanding94.43102.87100.02103.65133.95104.39122.03113.9259.2599.1466.1863.44106.6377.3464.9748.2682.1541.5335.97101.7542.1180.433.08K-
Inventory33.02M29.3M31.12M30.89M29.82M25.79M16.62M12.07M5.66M9.02M4.3M3.13M3.11M2.36M2.44M3.56M2.82M2.42M2.14M2.39M4.78M10.5M00
Days Inventory Outstanding18.5215.416.6518.5918.8520.1816.1714.057.8418.814.8312.7518.8915.7315.8728.7533.2836.4835.5335.1539.3189.17--
Other Current Assets66.55M24.75M13.42M27.87M43.82M20.68M21.04M6.13M25.27M17.03M2.68M3.39M2.51M2.11M1.16M721K01.43M951K027.89M03.15M0
Total Non-Current Assets929.5M1.02B1.23B1.35B1.18B1.13B1.03B852.81M522.11M487.02M182.13M121.6M99.3M104.85M137.32M134.88M105.17M77.64M89.82M96.04M91.71M104.14M5.41M6.99M
Property, Plant & Equipment531.39M554.39M823.94M806.56M650.2M484.6M412.7M268.53M90.52M74.66M43.42M38.33M24.05M24.24M27.18M24.95M18.49M19.16M18.47M18.46M34.67M38.16M4.44M4.46M
Fixed Asset Turnover1.16x1.37x0.97x0.97x1.16x1.28x1.21x1.66x4.15x3.45x3.79x3.33x3.72x3.55x3.21x3.21x2.99x2.23x2.14x1.78x1.94x1.68x0.44x0.80x
Goodwill0272.25M282.85M275.63M274.82M257.57M302.67M287.27M220.79M220.18M93.23M45.65M44.81M40.14M42.34M42.2M25.98M16.56M13.29M39.04M48.91M000
Intangible Assets031.56M26.44M15.45M23.82M30.85M119.95M131.33M122.99M135.03M22.45M25.15M30.21M39.83M63.27M67.65M57.62M29.01M47.17M37.48M42.99M14.13M16.34M0
Long-Term Investments218.02M52.61M42.15M142.09M150.33M287.01M72.22M46.31M28.99M22.14M3.97M80K91K87K85K-45.93M3.09M10K427K-57.06M-20.47M-93.44M00
Other Non-Current Assets37.33M36.84M37.82M95.23M74.08M56.84M45.73M26.56M15.5M15.77M8.47M3.57M139K566K1.63M46.01M3.09M12.9M10.47M58.12M1.98M159.42M192.53K779.74K
Total Assets1.64B1.78B1.91B2.25B2.26B2.24B1.84B1.38B771.88M667.27M351.37M288.54M224.6M227.38M225.43M218.21M191.86M146.6M182.9M207.88M205.53M186.11M70.91M41.73M
Asset Turnover0.41x0.43x0.42x0.35x0.33x0.28x0.27x0.32x0.49x0.39x0.47x0.44x0.40x0.38x0.39x0.37x0.29x0.29x0.22x0.16x0.33x0.34x0.03x0.09x
Asset Growth %-50.03%-7.03%-15.09%-0.21%0.99%21.63%33.18%78.76%15.68%89.91%21.77%28.47%-1.22%0.87%3.31%13.74%30.87%-19.85%-12.02%1.14%10.43%162.46%69.94%-
Total Current Liabilities423.82M367.92M344.58M464.57M337.71M324.52M255.06M200.88M196.28M245.78M73.39M56.4M33.07M38.95M33.88M42.83M32.8M26.45M21.83M24.34M55.48M29.67M7.61M5.15M
Accounts Payable54.96M64.74M85.79M134.32M97.28M72.6M52.06M35.16M31.14M26.08M12M12.17M9.45M6.65M6.36M10.13M6.98M5.24M7.19M15.09M11.48M8.11M1.25M543.91K
Days Payables Outstanding32.7734.0245.9180.8561.4956.850.6540.9243.1554.3741.3349.5357.3744.3841.2981.9482.4178.76119.43221.5894.3768.87--
Short-Term Debt88.71M103.64M50.8M149.1M1.56M36.14M36.72M23.27M55.07M167.76M21.41M14.21M13.36M17.22M13.22M13.17M8.58M10.27M2.58M1.3M2.59M6.04M1.05M1.25M
Deferred Revenue (Current)383.38M108.02M109.81M107.86M136.67M126.78M86.44M82.4M61.19M18.99M15.91M8.86M3.35M6.28M5.78M18.19M7.67M5.48M1.24M6.58M12.68M7.5M3.37M0
Other Current Liabilities155.82M41.18M84.21M45.83M76.54M63.93M31.68M17.17M16.74M29.44M10.23M6.91M6.91M6.67M5.36M13.13M7.26M4.99M8.74M7.06M40.21M11.67M5.28M3.03M
Current Ratio1.68x2.07x1.98x1.94x3.18x3.39x3.16x2.62x1.27x0.73x2.31x2.96x3.79x3.15x2.60x1.95x2.64x2.61x4.26x4.60x2.05x2.76x8.61x6.74x
Quick Ratio1.60x1.99x1.89x1.88x3.09x3.31x3.10x2.56x1.24x0.70x2.25x2.90x3.70x3.08x2.53x1.86x2.56x2.52x4.17x4.50x1.97x2.41x8.61x6.74x
Cash Conversion Cycle80.1884.2570.7641.3991.3167.7787.5687.0423.9563.5739.6826.6668.1548.6939.54-4.9333.03-0.74-47.93-84.69-12.95100.74--
Total Non-Current Liabilities517.36M596.72M615.39M667.99M732.36M532.96M696.2M643.51M150.73M89.75M64.04M45.04M33.15M29.46M39M28.14M26.42M8.67M11.21M12.99M12.88M7.77M1.58M543.12K
Long-Term Debt299.16M194.82M392.74M477.11M328.3M326.34M405.02M364.68M54.68M20.3M7.19M8.73M8.19M04.18M2.36M3.5M3.76M8.05M9.13M6.3M3.4M1.58M543.12K
Capital Lease Obligations149.04M149.04M0170.03M162M135.96M160.21M131.87M2.87M1.17M30K0014K01K32K132K346K700K1.83M2.13M00
Deferred Tax Liabilities121.92M79.51M14.52M18.14M18.52M17.69M73.39M78.08M21.52M23.5M115K1.54M1.58M1.25M2.1M9.9M6.66M1.98M1.46M1.6M6.45M000
Other Non-Current Liabilities65.58M19.74M20.9M-152.57M17.4M18.49M25.62M25.3M20.62M16.11M15.57M28.27M19.04M19.82M20.2M15.86M12.72M832K779K1.02M-2.82M1.51M00
Total Liabilities941.17M964.64M959.98M1.13B1.07B857.48M951.26M844.39M347M335.52M137.43M101.44M66.22M68.41M72.88M70.97M59.22M35.11M33.04M37.33M68.35M37.44M9.18M5.7M
Total Debt387.87M447.5M443.54M815.35M506.67M512.92M601.94M519.83M114.47M189.93M28.83M22.94M21.55M17.24M17.4M16.71M12.22M14.38M11.33M11.66M11.91M13.27M2.62M1.8M
Net Debt-450.47K29.16M137.15M304.44M105.98M-186.41M84.9M208.86M5.41M122.91M-55.11M-21.55M-27.16M-28.4M-21.66M-1.06M-8.87M-18.54M-43.74M-26.33M-66.82M-40.25M-1.49M404.16K
Debt / Equity0.55x0.55x0.47x0.73x0.43x0.37x0.68x0.97x0.27x0.57x0.13x0.12x0.14x0.11x0.11x0.11x0.09x0.13x0.08x0.07x0.09x0.09x0.04x-
Debt / EBITDA-9.44x--17.93x4.87x4.60x5.75x4.67x1.05x3.26x0.67x0.97x10.00x-3.10x1.41x1.69x-------
Net Debt / EBITDA0.01x--6.70x1.02x-1.67x0.81x1.87x0.05x2.11x-1.27x-0.91x-12.60x--3.86x-0.09x-1.23x-------
Interest Coverage-7.70x-9.75x-15.58x-5.87x-10.71x26.61x4.05x5.09x28.79x21.27x22.63x8.24x-2.91x-12.42x-2.32x3.83x5.47x-102.51x-89.55x-30.69x-49.32x-49.91x--
Total Equity700.35M813.36M952.52M1.12B1.19B1.38B886.41M535.47M424.88M331.75M213.94M187.09M158.38M158.97M152.55M147.25M132.64M111.49M149.86M170.55M137.18M148.67M61.06M-62.37M
Equity Growth %-77.92%-14.61%-14.95%-5.67%-13.83%55.42%65.54%26.03%28.07%55.07%14.35%18.13%-0.37%4.21%3.6%11.01%18.97%-25.61%-12.13%24.33%-7.73%143.47%197.9%-
Book Value per Share1.972.292.693.163.364.142.881.791.441.140.810.680.600.660.650.630.610.520.791.192.342.761.41-34.72
Total Shareholders' Equity700.35M813.36M952.52M1.12B1.19B1.38B886.41M535.47M424M330.75M213.03M185.5M158.38M158.97M152.55M147.25M132.16M110.87M149.86M170.55M137.18M148.67M61.06M-62.37M
Common Stock178.06M177.7M177.55M177.19M176.95M176.61M200.56M169.39M149.06M147.53M133.05M132.58M131.71M131.46M118.55M118.32M115.6M108.84M108.84M73.87M68.08M62.76M17.7K794
Retained Earnings-898.76M-775.56M-672.37M-476.29M-392.38M-216.42M-529.36M-495.22M-481.01M-566.73M-592.93M-622.31M-638.83M-631.85M-606.42M-608.89M-615.64M-618.9M-573.38M-495.09M-506.88M-474.41M-89.98M-65.14M
Treasury Stock-1.14M-1.55M0000000000000-1K000-99K-83K000
Accumulated OCI-38.36M-45.09M-7.35M-30.64M-37.4M-12.64M-45.91M-21.96M-27.2M-28.9M-25.15M-18.51M-23.17M-27.41M-25.5M-35.07M-26.68M-27.48M-26.84M-27.48M-65.31M000
Minority Interest00000000876K992K901K1.59M0000476K613K00-6K000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and solvency pressure

Balance Sheet Erosion Amidst Losses

As reported in financial statements, Evotec's total equity has declined from $1.1 billion in 2024Q3 to $700.3 million by 2026Q1, reflecting a persistent erosion of the capital base driven by ongoing net losses and the accumulation of a significant deficit in retained earnings.

The consistent decline in equity suggests that the company is consuming its internal resources to fund operations rather than generating self-sustaining growth. This trajectory warrants close monitoring, as the depletion of equity buffers reduces the company's financial flexibility during periods of operational stress.

Leverage Ratios Mask Underlying Fragility

Based on reported figures, Evotec maintains a debt-to-equity ratio of 0.55 as of 2026Q1, which appears deceptively stable while the company's ability to service this debt is increasingly compromised by the lack of consistent operating cash flow and a shrinking equity base.

While the headline leverage ratio remains within a manageable range, the reliance on debt to fund capital-intensive infrastructure like J.POD facilities creates a fixed-cost burden that is difficult to service without milestone-driven revenue. Investors should consider whether current debt levels are sustainable if the company fails to achieve a timely pivot to positive operating margins.

Asset Intensity Weighs on Returns

According to recent SEC filings, Evotec's net PPE remains a substantial component of the balance sheet at $531.4 million, indicating a heavy reliance on physical infrastructure that has yet to demonstrate the utilization rates necessary to drive meaningful return on invested capital.

The high concentration of assets in specialized laboratory and manufacturing facilities suggests an asset-heavy business model that is highly sensitive to volume fluctuations. This capital intensity creates a significant hurdle for profitability, as the depreciation of these assets continues to weigh on the bottom line regardless of current operational output.

Liquidity Buffer Shows Concerning Volatility

As evidenced by the quarterly data, Evotec's cash position fluctuated significantly from $510.9 million in 2023Q4 to $388.3 million in 2026Q1, highlighting a precarious liquidity profile that remains highly sensitive to the timing of milestone payments and ongoing operational cash burn.

The current ratio of 1.68 suggests a superficial level of liquidity, but the underlying volatility in cash balances indicates that the company lacks a stable cushion against unexpected operational shocks. This liquidity profile may necessitate further external financing if the company cannot stabilize its cash conversion cycle in the near term.

Retained Earnings Deficit Signals Risk

Based on the provided balance sheet data, the accumulation of a negative retained earnings balance reaching $898.8 million by 2026Q1 serves as a critical indicator of long-term value destruction that may not be fully captured by headline asset or debt figures.

This deep deficit suggests that the company's historical investments have not yet translated into sustainable profitability, raising questions about the long-term viability of the current capital allocation strategy. Investors should investigate whether this trend indicates a structural impairment of the business model rather than merely temporary operational headwinds.

EVO — Frequently Asked Questions

Quick answers to the most common questions about buying EVO stock.

What are the total assets of Evotec SE (EVO)?

As of 2025, Evotec SE (EVO) had total assets of $1.78B including $762.6M in current assets.

How much debt does Evotec SE (EVO) have?

Evotec SE (EVO) carries total debt of $447.5M, offset by $476.2M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Evotec SE?

Evotec SE (EVO) has total shareholders' equity (book value) of $813.4M ($2.29 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Evotec SE's current ratio and liquidity?

Evotec SE (EVO) reported a current ratio of 2.07x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.